PS1034 Phase I Dose Escalation Clinical Trial of H3B-8800, a Splicing Modulator, in Patients with Advanced Myeloid Malignancies (original) (raw)

PS1034 Phase I Dose Escalation Clinical Trial of H3B-8800, a Splicing Modulator, in Patients with Advanced Myeloid Malignancies

HemaSphere, 2019

Michael Maris hasn't uploaded this paper.

Let Michael know you want this paper to be uploaded.

Ask for this paper to be uploaded.